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ABSTRACT  
 
 
Purpose: to investigate clinical, demographic and dietary factors associated with 
constipation in a sample of community dwelling people with Parkinson’s disease, 
recruited through a specialist outpatient clinic. Partners / carers provided a 
convenience control group.  
Scope: Participants completed a baseline questionnaire (background information, diet 
and exercise, activities of daily living: mobility and manual dexterity, health-related 
quality of life (SF-12), stool frequency and characteristics, extent of concern due to 
constipation, laxative taking), and a four week stool diary. The Rome criterion was 
used to determine constipation status. Multiple regression methods were use to 
explore the correlates of constipation. Baseline data were provided by 121 people 
with Parkinson’s, (54 controls), of whom 73% (25%) met the Rome criterion. 
Prospective diary data from 106 people with Parkinson’s (43 controls) showed lower 
proportions: 35% (7%) meeting the Rome criterion. Constipation is predicted by 
having Parkinson’s disease (p= .003; odds ratio 4.80, 95% CI 1.64 to 14.04) and 
mobility score (p=.04; odds ratio 1.15, 95% CI 1.01 to 1.31), but not by dietary 
factors. Amongst people with Parkinson’s constipation is predicted by number of 
medications (p=.027). Laxative taking masks constipation, and is significantly 
associated with wearing protection against bowel incontinence (p=.009; odds ratio 
4.80, 95% CI: 1.48 to 15.52).  
Conclusions: constipation is disease-related, not a lifestyle factor. More research is 
needed on optimal management and laxative use. 
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INTRODUCTION 
 
 
Constipation is common in older people [1]. It adversely affects quality of life [2], 
and incurs significant healthcare costs for laxatives and the treatment of 
complications. Constipation is a symptom of neurological disease [3,4] and studies 
show that 50% [5] to over 70% [6] of people with Parkinson’s suffer from 
constipation; and the excess burden relative to age matched controls may be as high 
as 60% [7-10]. Laxatives are estimated to be taken by approaching 40% of people 
with Parkinson’s [6,10]. Constipation is one of several autonomic system failures 
associated with Parkinson’s [7-9,11-14]. Mamometric investigations show two 
causes: anorectal ‘outlet’ dysfunction, causing straining, and slow colonic transit, 
suggesting local / peripheral nervous system effects and CNS mechanisms underlie 
constipation [4,5,14-17]. 
  
Diagnosing constipation is difficult because it means different things to different 
people [3,14]. Infrequent bowel movement in the absence of other symptoms 
(straining, hard / lumpy stools, feeling of obstruction or incomplete evacuation) may 
lie within the normal spectrum [18].  Constipation is assessed by objective means (for 
example, self report of frequency), subjectively (expressions of ‘bothersomeness’ or 
concern caused by it) or behaviour (laxative taking or other self help measures).  
 
It is not known why only some people with Parkinson’s experience constipation. 
Improved understanding of the risk factors will help ensure that health professionals 
implement evidence – based management strategies [12].  The aim of this study was 
to investigate clinical, demographic and dietary factors associated with constipation 
in a sample of community dwelling people with Parkinson’s disease.  
 
 
METHODS 
 
Recruitment and data collection 
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Ethical approval was obtained from the local NHS ethics committee.  All people with 
Parkinson’s attending a specialist outpatient clinic (except new patients and those 
with a recorded diagnosis of dementia) were sent an information sheet about the study 
and a letter inviting them to take part. Where appropriate, a separate information 
sheet and invitation was enclosed for partners / carers, who were included in the study 
to provide a convenient control group, and one that shared food preparation 
arrangements. Those interested in participating contacted the research team, and 
attended an interview at their next clinic visit. Repeat invitations were mailed to non 
responders, but only after a 12 month delay, on ethical grounds.  At the clinic 
interview (conducted in private), a researcher received consent (separately for 
patients and partner / carers).  Partners were asked to self complete baseline 
questionnaires, whilst the researcher collected data from patients. The researcher then 
gave participants a four week stool diary, and explained how to complete it.  
Participants were phoned after two weeks to assess progress. Completed diaries were 
returned in prepaid envelopes.     
 
The target recruitment was 100 people with Parkinson’s, and record reviews 
suggested that about 80% of community dwelling patients would have a partner / 
carer who could be invited to join the control group. Sample size calculations 
suggested that if 100 people with Parkinson’s were recruited, using a 5% significance 
level, a comparison of patients with partner / carers (controls) will yield 80% power 
against a medium sized standardised difference of 0.6. 
 
Measurement of constipation 
 
The baseline questionnaire was used to collect retrospective self report information 
on participants’ experiences of constipation including: the extent to which 
constipation was a cause for concern; frequency of bowel movements; use of 
prescribed and purchased over-the-counter laxatives; self help measures (increased 
fluid, fibre, fruit and vegetable intake, other dietary change, extra exercise); soiling 
and use of protection due to bowel incontinence (see Table 3). The first version of the 
Rome criterion (Rome I) was used to objectively assess whether a participant suffered 
from constipation. This internationally recognised standard asks subjects whether, for 
at least a quarter of the time during the last three months, they have: had to strain 
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when opening their bowels; had lumpy / hard stools; had a sensation of incomplete 
evacuation; had less than three bowel movements per week. Constipation is present if 
the subject answers ‘yes’ to two or more of the four symptoms [19].  
 
To avoid inaccuracies from poor recall, diaries are recommended for collection of 
data on bowel function [20]. A bowel diary was purposefully developed for the study. 
Records were arranged one week to a page, and participants were asked to note daily 
the date and time of each bowel movement, (zero if no bowel opening), and use of 
laxatives / home remedies. Further information was recorded for each bowel 
movement: minutes spent, whether they felt empty afterwards (yes/ no), straining (0= 
none, 1= mild, 2= moderate, 3= severe), stool consistency (referring to pictures on the 
Bristol Stool Form Chart [21], range 1, separate hard lumps, like nuts (difficult to 
pass) to 7, watery, no solid pieces, entirely liquid). A sample of 12 diaries was 
independently reviewed by six nurses and continence advisors who concluded that the 
data generated were reliable and complete, enabling appropriate clinical 
interpretations to be drawn. Diary data were analysed to assess whether the bowel 
activity recorded met the Rome criterion (see footnote to Table 5). Participant’s 
constipation status reported retrospectively at baseline was compared with that 
recorded prospectively in the diary. 
 
Other variables 
 
Baseline questionnaires were used to collect data from patients and partner / carers on 
factors potentially associated with constipation: socio – demographic, economic 
characteristics; life style behaviours, including exercise, liquid, fruit / vegetable and 
fibre intake; activity of daily living (ADL) disability measure [22]; physical and 
mental functioning component summary scores (PCS and MCS) of SF – 12 [23], an 
internationally validated measure of health- related quality of life (Table 2).  Clinical 
information for people with Parkinson’s was extracted from medical notes by a 
Parkinson’s specialist nurse: Hoehn and Yahr disease stage [24], number of co-
morbidities and prescribed medications; taking COMT inhibitors (yes/ no - because 
diarrhoea is a side effect); taking agonists or anticholinergics (yes/ no - because 
constipation is a side effect). 
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Statistical analysis 
 
Data were entered into SPSS version 14.  Basic analyses were undertaken using t-
tests, Pearson’s correlation, ANOVA and contingency table tests as appropriate. 
Correlates of constipation (socio- economic and demographic, lifestyle behaviours, 
ADL, Parkinson’s status) were explored using multiple regression and multiple 
logistic regression, with the Rome criterion (>= 2 symptoms) from the background 
questionnaire as the dependent variable. Patient only analyses additionally included 
clinical features: disease stage, number of co-morbidities and medications, whether or 
not taking COMT inhibitors, agonists, anticholinergics, and the presence / absence of 
dementia and hypotension. Statistical significance was attained at p<.05. 
 
 
RESULTS 
 
Characteristics of samples 
 
A total of 238 people with Parkinson’s and 188 partner /carers (controls) were invited 
to participate over a 2 year period (2005 – 7).  Consent and baseline information was 
obtained from 121 (50.8%) people with Parkinson’s and 54 (28.7%) partners / carers. 
Of these, 106 (87.6%) people with Parkinson’s and 43 (79.6%) carers returned stool 
diaries.  Recruitment continued beyond the planned target of 100 people with 
Parkinson’s to increase the size of the control group.  
 
About one half of people with Parkinson’s recruited were Hoehn and Yahr stage 2 
and reported no other health conditions (Table 1). A higher proportion of people with 
Parkinson’s than partner / carers were male; there were no significant differences 
between groups in other socio – demographic, economic variables (Table 2).   People 
with Parkinson’s reported relatively high levels of independence (mean of 2, i.e. able 
to do activity alone with a little effort, on each item of the ADL disability scale), but 
in comparison to controls, their mobility, manual dexterity and PCS scores were 
significantly worse. Partners / carers reported eating significantly more fruit and 
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vegetables, but there were no differences between groups in other self reported 
behaviours (Table 2).   
 
TABLES 1 AND 2 GO HERE 
 
Baseline reporting of constipation 
 
On each measure, people with Parkinson’s were significantly more likely to report 
constipation than controls (Table 3). Measures of constipation were closely correlated 
(Table 4). Patients (controls) stating that constipation caused them a lot of concern 
were 8.26 (11.5) times more likely to be taking any laxative, and 14 (7.2) times more 
likely to be constipated according to the Rome criterion than people who stated they 
were not greatly concerned by constipation.  
 
TABLES 3 AND 4 GOES HERE 
 
Bowel incontinence 
 
Nine percent of respondents with Parkinson’s, 3.7% of partner / carer controls, 
reported wearing protection against faecal incontinence (Table 3). This behaviour was 
significantly associated with taking any laxative (p=.009). Of the 13 people wearing 
protection, 8 (61.5%) take laxatives, compared to 40 of 165 (24.7%) of those not 
wearing protection. People taking a laxative are almost five times more likely to wear 
protection than those who do not take a laxative (odds ratio 4.80, 95% CI: 1.48 to 
15.52). This relationship persists even after allowing for Parkinson’s status (p=.019; 
odds ratio 4.25, 95% CI: 1.27 to 14.29).   
 
Stool diary analysis 
 
People with Parkinson’s were significantly more constipated than controls (Table 5). 
Lower proportions of people with Parkinson’s and of partner / carers were defined as 
constipated (Rome criterion) in the diary analysis than in retrospective reporting at 
baseline (35% vs 73%, 7% vs 24.5% respectively). There was no difference in 
constipation status at baseline between the people who completed the stool diary and 
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those who did not, nor between the characteristics of people whose constipation status 
changed between baseline and diary and the characteristics of those whose status did 
not (data not shown).  
 
TABLE 5 GOES HERE 
 
Diaries show laxatives (and home remedies such as fibre) were taken by 45, 42.4% 
(11, 10.4%) of people with Parkinson’s and 2, 4.6% (0) of partner / carers at least 
once during the 28 day observation period. The mean number of days laxatives (home 
remedies) were taken was 10 (6). Eight patients who took home remedies also used 
laxatives.   Twenty three (21.7%) patients and 2 (4.7%) partner / carers reported 
taking laxatives at least once per week. The equivalent rates at baseline were 35% 
(11%). Patients taking daily laxatives (n=7) had the highest mean frequency of stools 
(1.04, range 0.9 – 2.3). Over half of patients (n=61, 57.5%) reported no laxative use 
in their diaries and a mean of 1.0 stools per day (0.3 – 3.9).  The lowest stool 
frequency was recorded by occasional (once or twice a week) laxative users (0.73, 0.5 
– 1.0). 
 
Correlates of constipation   
 
In multiple regression analysis, the only factors predictive of constipation were 
having Parkinson’s disease (p= .003) and ADL mobility (p=.04).  People with 
Parkinson’s are nearly five times more likely to meet the Rome criterion than partner 
/ carer controls (odds ratio 4.80, 95% CI 1.64 to 14.04). An increase of one unit in 
ADL mobility score raises the odds of meeting the Rome criterion by 1.15 (95% CI 
1.01 to 1.31).  When the two ADL variables are not in the model, only a diagnosis of 
Parkinson’s disease is a significant predictor of constipation (odds ratio 9.38, 95% 
CIs 3.91 to 22.52).  
 
Stating that constipation has been a cause for concern over adult life is significantly 
associated with meeting the Rome criterion at baseline (p=.031), including when 
Parkinson’s diagnosis is incorporated in the model (p=.048).  Hence, patients and 
partners / carers reporting constipation at baseline are equally likely to have reported 
concern over constipation throughout their adult life. 
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Amongst patients, a significant association exists between constipation and number of 
medications (p=.027), the major effect coming from taking >=4 medications (odds 
ratio relative taking 0 or 1 medication 8.62, 95% CI 1.60 to 46.45).  There is no 
evidence of any association between constipation and number of comorbidities, 
having hypotension, or taking COMT inhibitors, agonists or anticholergineric 
medications.  
 
 
DISCUSSION 
 
The study confirms higher levels of self reported constipation amongst people with 
Parkinson’s than partner / carer controls. The excess burden (according to Rome I 
criterion) amongst patients, compared to partner / carer controls (48% at baseline 
(73% vs 25%), and 28% (35% vs7%) stool diary) is comparable to other studies [7-
10]. Retrospectively, respondents self report higher levels of constipation according 
to the objective Rome criterion than by subjective (cause of concern) and behavioural 
(use of laxatives or other self help measures) indicators. The lower level of 
constipation reported through prospective diary data contrasts with other research 
which suggests that diaries over estimate constipation by under reporting stool 
frequency [5]. In this study, the discrepancy may arise because the retrospective 
reporting at baseline used the validated Rome criterion, with a 3 month reference 
period, but the diary data was collected over four weeks (to avoid jeopardising data 
quality by increasing participant burden). Applying the Rome criterion to one month 
of data might be expected a priori to result in a lower observed frequency of 
constipation because less time has elapsed for constipation episodes to occur. 
 
Data from the baseline questionnaire suggest that only ADL mobility and having a 
diagnosis of Parkinson’s disease are significantly associated with constipation. The 
link between female gender and psychological morbidity and constipation identified 
by other researchers [3,15,25] was not found. In the patient sample, the number of 
medications taken is an independent predictor of constipation. Anticholinergic 
medications are known to have a constipating side effect (26,29,45), but may not have 
been significant in our study because relatively small numbers of patients were taking 
  
10 
 
them. Unlike other studies, the evidence reported here failed to find an association 
between constipation in Parkinson’s and the disease process severity, diet or activity 
[4,7,12,26] and low fibre, fluid intake or lack of exercise [5,14,16,17]. This may be 
because the data collection was not sufficiently detailed, or ‘doses’ were inadequate 
[2,27].  
 
High proportions of people with Parkinson’s report straining, a sign of anorectal 
dysfunction (53), but there is less evidence of low frequency, a sign of slow transit, 
possibly because it is masked by laxative taking. Only 13 (12.3%) people with 
Parkinson’s completing the diary show less than four bowel movements per week 
across the 28 days. Higher stool frequency is associated with taking more laxatives, 
and there is some evidence that this is linked to bowel incontinence. No evidence was 
found that having Parkinson’s is associated with reporting constipation over adult life 
despite other studies suggesting that constipation is a preclinical indicator [16,28,29]. 
 
The data used in the analysis are robust. Baseline questionnaires were administered 
by researchers in a clinic setting, and recognised objective measures of constipation 
(Rome I, and Bristol Stool Form Chart) were used.  The stool diary was 
independently validated by a panel of experienced nurses. The four week reporting 
period allows sufficient time for usual patterns to be observed. Participants who 
completed diaries undertook the task seriously and recorded data meticulously such 
that missing observations were minimal.  
 
The limitations of this study are that partner / carer recruitment fell short of 
expectations (47 vs 78). Many partners/ carers were not willing to take part, and this 
affected the statistical comparisons between groups. Other trials of constipation have 
also reported problems recruiting participants due to the sensitive nature of the 
subject [18]. The representativeness of people recruited to the study is not known.  
Gender imbalance in the sample (more women in the carer group than patient group) 
may affect the interpretation of the findings if constipation is not equally experienced 
by men and women.  The patient sample covered all disease stages, although 50% 
were Hoehn and Yahr stage 2, and as a group, they reported relatively little disability 
in ADL. The most up-to-date version of the Rome criterion [30] was not used in the 
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study because, in piloting, participants found the lengthened reference period (12 
rather than three months) problematical.  
 
This study suggests that constipation is disease related, rather than a life style issue. 
Constipation – related problems cause daily concern for significant numbers of 
people, and there is a need for further research into optimal management regimens, 
including robust trials to provide an evidence-base for practitioners.  
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TABLE 1: Clinical characteristics of participants with Parkinson’s disease*  
 
Characteristic n Values Frequency % 
Hoehn and Yahr disease  
stage 
106 Stage 1 5 4.7 
Stage 2 53 50.0 
Stage 3 44 41.5 
Stage 4 4 3.8 
Number of comorbidites 
Mean 0.93 
Standard Deviation 1.14 
108 None 53 49.1 
1 25 23.2 
2 20 18.5 
3 6 5.6 
4 or more 4 3.7 
Number of medications 
Mean 2.76 
Standard Deviation 1.72 
108 None 5 4.6 
1 16 14.8 
2 34 31.5 
3 27 24.5 
4  15 13.9 
5 or more 11 10.3 
Takes COMT inhibitor 108 Yes 8 7.4 
Takes dopamine agonist 108 Yes  71  65.7 
Takes anticholinergic  108 Yes 5  4.6 
 
* Clinical data were available from the medical notes of 108 of the 121 people with 
Parkinson’s who consented to participate in the study (89.3%)
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TABLE 2: Socio – demographic, economic, diet, activity and health related quality of life: 
comparison of people with Parkinson’s and partners / carers (controls) 
Item Responses People with 
Parkinson’s (PwP) 
 n=121* 
Partners /Carers  
(Controls) 
n=54* 
Significant 
difference 
PwP vs  
Controls n % n % 
Gender  Male 73 60.3 18 33.3 p= .001 
Mean age (n=52 carers) In years 69.8 SD = 8.5 68.1 SD = 9.9 p=.342 
Highest level of 
education  
Below age 15/16 51 42.8 19 35.2 <= 18 vs >18 
p=.992 Age 17/18 13 10.9 10 18.5 
College 36 30.3 19 35.2 
University 19 16.0 5 9.3 
Employment status Full time  8 6.6 3 5.6 Employed vs 
not employed 
p =.942 
Part time 5 4.1 3 5.6 
Retired 106 87.6 46 85.2 
Other 2 1.7 2 3.8 
Household net annual 
income  
(n=100 PwP,  
n= 43 carers) 
< £10,000 18 18.0 7 16.3 p= .599 
£10,000 – 19,999 41 41.0 17 39.5 
£20,000 – 20,999 20 20.0 10 23.2 
>= £30,000 21 21.0 9 20.9 
ADL disability scale# 
(n= 120, 113 PwP, 
n = 51, 46 carers) 
 High is worse 
8 item Mobility 
(range 8-40) 
Mean 
15.6 
SD=5.9 Mean 
9.5 
SD=3.1 p<.001 
14 item Manual 
dexterity (14-70)  
Mean 
27.7 
SD=9.9 Mean 
14.8 
SD=1.7 p<.001 
HRQoL:SF-12  
(n= 52 carers) 
Worst 0 - 100 Best 
PCS mean 35.9 SD=11.3 45.7 SD=9.8 p<.001 
MCS mean 43.3 10.0 44.5 9.5 p=.442 
How often do you 
exercise per day, not 
including normal 
duties? 
Every day 58 47.9 18 33.3 > = once per 
week vs  
< once  per 
week 
p =.839 
2 -3 times per week 22 18.2 19 35.2 
About once a week 17 14.1 7 13.0 
1-2 times / month 2 1.7 0 0 
Rarely, never 20 16.5 9 16.7 
Don’t know 2 1.7 2 4.6 
Type of exercise 
(n=97 PwP, n= 43 
carers). Other: bowling, 
gym, weights, tennis, 
gardening,cycling, golf, 
aerobics, exercise bike. 
Walking 52 53.6 31 72.1 Walking v rest 
p=.060 Swimming 3 3.1 1 2.3 
Stretch / yoga 6 6.2 0 0 
Physiotherapy 14 14.4 1 2.3 
Other  22 22.7 10 23.3 
Cups of liquid per day 
 
0 -4 (score 1) 24 19.8 5 9.3 0-8 vs >=9 
p =.179 5 – 8 (score 2) 74 61.2 35 64.8 
> = 9  (score 3) 23 19.0 14 25.9 
Portions of fruit and 
vegetables per day 
(n= 53 carers) 
0 (score 1) 2 1.7 0 0  
0-2 vs >2 
p=.163 
1 – 2 (score 1) 25 20.7 7 13.2 
3 – 4 (score 2) 51 42.2 21 39.6 
>=5 (score 3) 43 35.5 25 47.2 
Choose high fibre bread 
(n=120 PwP) 
Always/usually 
(score 3) 
72 60.0 37 68.5 Always/ 
usually vs rest  
p =.283 Sometimes (score 2) 37 30.1 14 26.0 
Never (scores 1) 11 9.2 3 5.5 
‘Bowel friendly diet’ 
score: (n=120 PwP, 
n=53 carers). 
Score from sum of 3 
diet variables above 
(Range: 3-9) 
Mean 
6.48 
SD=1.38 Mean 
7.11 
SD=1.20 p=.003 
Key: * Missing observations for some variables; SD: Standard Deviation;  
           ADL: Activities of Daily Living Disability (45), 25 items measured on a 5 point scale across 2 dimensions (Mobility 
and Dexterity): 1= able to do it alone without difficulty to 5 = unable to do it at all.  Items relating to use of public 
transport and getting in and out of the bath were not applicable to many respondents and removed from the analysis. 
           HRQoL: Health Related Quality of Life from SF-12 (46); PCS / MCS: Physical / Mental Component Summary 
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TABLE 3: Reporting of constipation: comparison of people with Parkinson’s and partner / 
carer (controls) from baseline questionnaires 
 
Item Responses People with Parkinson’s 
(PwP) 
 n=121* 
Partners /Carers  
(Controls) 
n=54* 
Significant 
difference 
PwP vs  
Controls n % n % 
How often do you 
currently suffer 
from constipation? 
Always/v often 32 26.5 1 1.9 Always/very 
often vs rest 
p =<.001 
Quite often  19 15.7 2 3.7 
Sometimes 31 25.6 12 22.2 
Never / rarely 39 32.2 39 72.2 
To what extent is 
constipation a 
cause of concern? 
A lot 28 23.1 4 7.4 A lot vs little, not 
at all 
p = .013 
A little 43 35.5 5 9.3 
Not at all 50 41.3 45 83.3 
Over your adult 
life, how often has 
constipation been a 
cause of concern? 
Always/v often 5 4.1 3 5.6 Always, quite 
often vs 
sometimes, 
never: p = .809 
Quite often  10 8.3 3 5.6 
Sometimes 17 14.1 7 13.0 
Never / rarely 89 73.6 41 75.9 
How often do you 
open your bowels 
on a typical day?  
Mean number of times 
per day 
0.96 
(n=120) 
SD= 
0.72 
1.36 
(n=52) 
SD=  
0.77 
p=.002 
Rome criterion: for 
at least a quarter of 
the time during the 
last 3 months have 
you had: 
 
to strain when opening  
your bowels? Yes 
84 
(n=120) 
70.0 13 
(n=52) 
25.0 p<.001 
lumpy or hard stools?  
Yes 
78 
 
64.5 12 
(n=49) 
24.5 p<.001 
sensation of incomplete 
evacuation? Yes 
67 
 
55.4 16 
(n=50) 
32.0 p=.005 
2 or fewer bowel 
movements / week?Yes 
32 
(n=120) 
26.7 3 
(n=49) 
6.1 p=.003 
Mean number of 
symptoms. (Range 0-4) 
2.17 
(n=119) 
SD= 
1.28 
0.88 
(n=49) 
SD= 
1.20 
p<.001 
 
Constipated by 
Rome criterion 
Yes to >=2 symptoms 87 
(n=119) 
73.1 12 
(n=49) 
24.5 >=2 vs <2 
p<.001 
In the last 7 days, 
have you taken: 
laxatives prescribed by 
Doctor? [1]  Yes 
25 
(n=120) 
20.8 4 
 
7.4 Yes vs No  
p=.028 
In the last 7 days, 
have you taken  
laxatives you bought 
from a chemist?[2]Yes 
24 
(n=120) 
20.0 4 
 
7.4 
 
Yes vs No  
p=.036 
In the last 7 days, 
have you taken  
any laxatives?  
Yes 
42[3] 
(n=119) 
35.3 6[3] 
 
11.1 Yes vs No  
p=.001 
In the last 7 days, 
have you tried any 
of the following 
(self help) means 
of dealing with 
constipation? 
Increased fluid intake? 
Yes 
22 
(n=119) 
18.5 4 
(n=46) 
8.7 p=.122 
 
Increased fibre intake?  
Yes 
26 
(n=119) 
21.9 4 
(n=45) 
8.9 p=.055 
 
Increased exercise?  
Yes 
16 
(n=119) 
13.5 1 
(n=46) 
    2.2 p=.033 
 
Eaten more fruit/ 
vegetables? Yes 
43 
(n=119) 
36.1 7 
(n=46) 
15.2 p=.009 
 
Eaten/ avoided certain 
food?  Yes 
19 
(n=118) 
16.1      2 
(n=45) 
4.4 p=.047 
At least a quarter 
of the time, do you  
have pain opening your 
bowels? Yes 
22 
(n=120) 
18.3 6 
(n=48) 
12.5 p=.359 
Do you use finger 
to help empty 
bowels? 
Always/ Often 4 3.4 1 1.7 Always, often vs 
sometimes, never 
p =.606 
Sometimes 8 6.6 0 0 
Never / rarely 109 90.1 53 98.3 
Do you get soiling 
after opening your 
bowels? 
Always/ Often 9 7.5 1 1.7 Always, often vs 
sometimes, never 
p =.141 
Sometimes 16 13.2 5 9.3 
Never / rarely 96 79.3 48 88.9 
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Do you wear  protection for bowel 
incontinence?  Yes 
11 9.1 2 3.7 p=.209 
In the past 6 
months, have you  
had haemorrhoids 
(piles) or bleeding from 
back passage?[5] Yes 
23 
(n=118) 
19.5 12 
(n=52) 
23.1 p=0.594 
used suppositories for 
constipation? Yes 
12 
(n=106) 
11.3 2 
(n=32) 
6.3 p=0.405 
had an enema for 
constipation? Yes 
3 
(n=103) 
2.9 1 
(n=29) 
3.5 p large 
used any CAM for 
constipation? [4] Yes 
4 
(n=103) 
3.9 1 
(n=28) 
3.6 p large 
 
Have you ever  been hospitalised for 
constipation?   Yes 
5 
(n=116) 
4.3 1 
 
1.9 p=.419 
Key:      * Missing observations for some variables; SD: Standard Deviation  
Notes:    [1] Prescribed laxatives mentioned: Movicol, senna, dioctyl, manevec, fybogel, lactulose 
       [2] Laxatives reported purchased ‘over-the-counter’: senna, fybogel, lactulose, exlax, fruit cubes, dulcolax, syrup 
of figs, Epsom salts, ortisan 
[3] Of the 42 people with Parkinson’s (6 controls) who took any laxative, 6 (2) took both prescribed and laxatives 
purchased from chemist 
       [4] CAMs (Complementary or Alternative Medicine) reported: ortisan, reiki 
       [5] Any reports of bleeding were referred to the doctor 
     
 
  
20 
 
TABLE 4: Associations between measures of constipation in the baseline questionnaires 
 
Measures of constipation Patients Carers 
Odds ratio 95% CI Odds ratio 95% CI 
Now of concern vs Rome 13.95 1.74 to 112.13 7.20* 0.56 to  92.37  
Now of concern v any laxative 8.26 3.02 to 22.60 11.50 1.21 to 109.69 
Now of concern v any self help 1.97* 0.80 to 4.81 11.67* 0.86 to 157.70 
Rome v any laxative 12.72 2.77 to 58.39 5.83* 0.80 to 39.24 
Rome v any self help 3.49 1.41 to 8.64 22.50 3.20 to 158.05 
Any laxative v any self help 2.59 1.16 to 5.81 11.67* 0.86 to 157.70 
 
Key: * Not significant 
Notes: Subjective measure: Constipation is currently a cause for concern (a lot vs not a lot ) 
           Objective measure: Meets Rome criterion (reports >= 2 symptoms) 
           Behavioural measures: in the last 7 days, taken any laxative; taken any self help measure 
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TABLE 5: Bowel activity reporting: comparison of people with Parkinson’s and partner / 
carer (controls) from 28 day diaries. 
 
 
 
* There was minimal missing information. Most participants completed the full 28 
days of record keeping (people with Parkinson’s: mean 25.8 days; SD 4.5; median 28; 
range 2 - 30; partners / carers: mean 27.2 days; SD 1.8; median 28; range 20 - 28).  
 
$ From Bristol Stool Form Chart [21] 
 
# To meet the Rome criterion: for at least a quarter of the time any two of the 
following symptoms must be present: straining when opening bowels (defined as a 
mean straining score >1 from diary entries); lumpy or hard stools (mean Bristol stool 
score <3); sensation of incomplete evacuation (report not feeling bowels empty > 
33% of bowel movements); <3 bowel movements per week (mean of < 3/7 = 0.43).  
 
 
      People with Parkinson’s  
               (PwP) n=106* 
              Partner / Carer 
              (Controls)  n = 43* 
Significant 
difference 
PwP vsControls Mean SD Min. Median  Max. Mean SD Min. Median  Max. 
Mean number of bowel 
movements / day 
.95 .41 .21 .92 2.4 1.19 .42 .5 1.07 2.75 p=.003 
Mean strain level 
(0 none – 3 severe) 
.94 .63 0 .93 2.7 .39 .43 0 .23 1.4 p<.001 
% bowel movements  
with straining 
62.0 33.6 0 79.3 100 30.9 30.4 0 23.3 100 p<.001 
Mean consistency (1 
very hard – 7 liquid)$ 
3.4 1.1 .5 3.4 5.7 3.7 .74 2.0 3.7 5.9 p=.034 
% bowel movements 
hard stools (1,2)$ 
26.6 31.0 0 11.6 100 11.3 18.2 0 5.9 92.3 p<.001 
% bowel movements 
soft stools (6,7)$ 
7.2 15.0 0 0 87.5 4.4 10.1 0 0 55.1 p=.18 
% bowel movements 
not felt empty 
35.7 33.2 0 26.6 100 12.3 16.8 0 7.1 83.3 p<.001 
Mean time spent 
(minutes) 
3.7 3.8 .12 2.6 25.8 2.1 2.4 .16 1.2 11.1 p=.002 
% of days laxatives 
taken 
13.4 27.5 0 0 100 2.5 14.3 0 0 92.9 p=.002 
% of days use self 
help measure 
2.3 9.6 0 0 75.0 0 0 0 0 0  
Meet Rome criterion  
for constipation# 
n = 37 (34.9%) 
 
n = 3  (7.0%) 
 
p<.001        p=.003 
 
